Knight Therapeutics Inc. (FRA:04K)

Knight Therapeutics Statistics

Total Valuation

FRA:04K has a market cap or net worth of EUR 370.20 million. The enterprise value is 362.88 million.

Market Cap	370.20M
Enterprise Value	362.88M

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	99.29M
Shares Outstanding	n/a
Shares Change (YoY)	-1.93%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	22.93%
Owned by Institutions (%)	15.46%
Float	61.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	194.09
PS Ratio	1.46
PB Ratio	0.79
P/TBV Ratio	2.04
P/FCF Ratio	18.01
P/OCF Ratio	17.02
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.71, with an EV/FCF ratio of 17.65.

EV / Earnings	-169.78
EV / Sales	1.43
EV / EBITDA	13.71
EV / EBIT	n/a
EV / FCF	17.65

Financial Position

The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.14.

Current Ratio	2.62
Quick Ratio	1.63
Debt / Equity	0.14
Debt / EBITDA	2.47
Debt / FCF	3.16
Interest Coverage	-1.29

Financial Efficiency

Return on equity (ROE) is -0.45% and return on invested capital (ROIC) is -0.84%.

Return on Equity (ROE)	-0.45%
Return on Assets (ROA)	-0.72%
Return on Invested Capital (ROIC)	-0.84%
Return on Capital Employed (ROCE)	-1.29%
Revenue Per Employee	339,905
Profits Per Employee	-2,869
Employee Count	745
Asset Turnover	0.41
Inventory Turnover	1.84

Taxes

Income Tax	-4.01M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+3.91%
50-Day Moving Average	3.63
200-Day Moving Average	3.75
Relative Strength Index (RSI)	53.31
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:04K had revenue of EUR 253.23 million and -2.14 million in losses. Loss per share was -0.02.

Revenue	253.23M
Gross Profit	107.61M
Operating Income	-7.05M
Pretax Income	-6.15M
Net Income	-2.14M
EBITDA	24.10M
EBIT	-7.05M
Loss Per Share	-0.02

Balance Sheet

The company has 72.29 million in cash and 65.01 million in debt, giving a net cash position of 7.28 million.

Cash & Cash Equivalents	72.29M
Total Debt	65.01M
Net Cash	7.28M
Net Cash Per Share	n/a
Equity (Book Value)	469.19M
Book Value Per Share	4.71
Working Capital	151.76M

Cash Flow

In the last 12 months, operating cash flow was 21.76 million and capital expenditures -1.20 million, giving a free cash flow of 20.55 million.

Operating Cash Flow	21.76M
Capital Expenditures	-1.20M
Free Cash Flow	20.55M
FCF Per Share	n/a

Margins

Gross margin is 42.49%, with operating and profit margins of -2.78% and -0.84%.

Gross Margin	42.49%
Operating Margin	-2.78%
Pretax Margin	-2.43%
Profit Margin	-0.84%
EBITDA Margin	9.52%
EBIT Margin	-2.78%
FCF Margin	8.12%

Dividends & Yields

FRA:04K does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.93%
Shareholder Yield	1.93%
Earnings Yield	-0.58%
FCF Yield	5.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:04K has an Altman Z-Score of 2.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	3